dt 5461 has been researched along with Shock, Septic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, I; Fujihara, M; Fukushima, A; Saiki, I; Sato, K; Takahashi, TA; Tono-Oka, S; Yoo, YC | 1 |
1 other study(ies) available for dt 5461 and Shock, Septic
| Article | Year |
|---|---|
A novel synthetic lipid A analog with low endotoxicity, DT-5461, prevents lethal endotoxemia.
Topics: Animals; Disaccharides; Female; Galactosamine; Humans; In Vitro Techniques; Interleukin-1; Lipid A; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Monocytes; Shock, Septic; Tumor Necrosis Factor-alpha | 1995 |